AVRO News and Press, AVROBIO Inc. From 07/22/19

Gainers: PRCP   +12.2% . PHM   +1.8% . AVRO   +1.5% . More news on: Perceptron, Inc., PulteGroup, Inc., AVROBIO, Inc., Stocks on the move, Read more ...

Listen on the go! Subscribe now to receive Wall Street Breakfast by 8:00 a.m. every trading day, and by 10:00 a.m. every Saturday, on Seeking Alpha , iTunes , Stitcher and Spotify (click the highlighted links). Stocks faded into the close to finish lower Friday, capping t...

AVROBIO, Inc. (NASDAQ: AVRO) (the “Company”), a Phase 2 clinical-stage gene therapy company, today announced the closing of its previously announced underwritten public offering of 7,475,000 shares of its common stock, including 975,000 shares of its common stock pursuant to t...

July 18, 2019 Palm Beach, FL –July 18, 2019 – Acute myeloid leukemia (AML) is a cancer that is rarely seen before age 45 with the average age of onset around 65. It is the most common of the four major types of leukemia. Without treatment, AML is often deadly wi...

Gainers:  Nautilus (NYSE: NLS ) +21% . Francesca's Holdings (NASDAQ: FRAN ) +20% . Anixa Biosciences (NASDAQ: ANIX ) +19% . AVROBIO (NASDAQ: AVRO ) +19% . Rekor Systems (REKR) +18% . Seattle Genetics (NASDAQ: SGEN ) +18% . Hill International (NYSE: HIL ) +18% . scPharmaceutical...

Francesca's Holdings (NASDAQ: FRAN ) +58% . More news on: Francesca's Holdings Corporation, Yatra Online, Inc., Vislink Technologies, Inc., Stocks on the move, Read more ...

AVROBIO (NASDAQ: AVRO ) has priced its public offering of 6.5M common shares at $18.50 per share, for gross proceeds of ~$120.25M. More news on: AVROBIO, Inc., Healthcare stocks news, Read more ...

AVROBIO, Inc . (NASDAQ: AVRO) (the “Company”), a Phase 2 clinical-stage gene therapy company, today announced the pricing of an underwritten public offering of 6,500,000 shares of its common stock at a public offering price of $18.50 per share. Gross proceeds from the underwrit...

AVROBIO, Inc. (NASDAQ: AVRO) (the “Company”), a Phase 2 clinical-stage gene therapy company, today announced that it intends to offer and sell, subject to market and other conditions, $100.0 million of its common stock in an underwritten public offering. The Company expects ...

Gainers:  Immuron (NASDAQ: IMRN ) +81% . Blue Apron Holdings (NYSE: APRN ) +49% . Moxian (NASDAQ: MOXC ) +35% . GAIN Capital Holdings (NYSE: GCAP ) +32% . Lonestar Resources (NASDAQ: LONE ) +19% . AVROBIO (NASDAQ: AVRO ) +17% . Dolphin Entertainment (NASDAQ: DLPN ) +16% . Bio-P...